Programme DES Nations Unies Pour LE Pharmaceutical Import Profile — Congo (DGFT 2022–2026)

Name: Programme DES Nations Unies Pour LE Pharmaceutical Import Records from India — 2 Products, $500.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Programme DES Nations Unies Pour LE — Pharmaceutical Importer Profile (2026) | 2 Products, $500.0K Trade | TransData Nexus

Programme DES Nations Unies Pour LE

Pharmaceutical Importer · Congo · Advanced Antibiotics Focus · $500.0K Total Trade · DGFT Verified

Programme DES Nations Unies Pour LE is a pharmaceutical importer based in Congo with a total trade value of $500.0K across 2 products in 1 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Programme DES Nations Unies Pour LE sources from 7 verified Indian suppliers, with Emcure Pharmaceuticals Limited accounting for 57.3% of imports.

Programme DES Nations Unies Pour LE — Import Portfolio & Supplier Network

Programme DES Nations Unies Pour LE import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Programme DES Nations Unies Pour LE?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Emcure Pharmaceuticals Limited	$746.5K	18	57.3%
Micro Labs Limited	$240.1K	5	18.4%
Lupin Limited

What Formulations Does Programme DES Nations Unies Pour LE Import?

Formulation	Value	Ships
Trimethoprim and sulfamethoxazole	$140.1K	3
Atazor r 300 100MG tablets atazanavir 300MG ritonavir USP 100MG 1x30tabs inv no 2302100441 dt 22 02 2023 1pac	$100.0K	2
Pharmaceutical products (finished	$87.5K	2
Pharma : 2 fdc (150/75) tablets paho (eng/sp/por/fr) (rifampin 150MG + isoniazid75mg) - 1boxx24x28	$67.7K	2
Material no.- 44093304 rifampicin	$50.0K	1
Atazor r 300 100MG tablets atazanavir 300MG ritonavir USP 100MG 1x30tabs 01pac 01no inv no 2303100450 dt 01 03	$50.0K	1
Atazor r 300/100MG tablets(atazanavir	$50.0K	1
Atazor r 300/100MG tablets (atazanavir	$50.0K	1
Pharmaceutical products : atazor r	$50.0K	1
Pharma:atazor-r 300/100MG	$50.0K	1
Trimethoprim and sulfamethoxazole tablets BP 80MG /400 MG(who pq number:ha 598)(1x500 s)(qty- 25675.000)(cotrimoxazole)	$50.0K	1
Pharma : rifa 75 & iso 50 tablets undp	$50.0K	1
Pharma : rifapentine 300 + inh 300	$50.0K	1
Pharma : instgra 50MG tablets wtc (dolutegravir tablets 50MG) - 1x30 tabs (inv.no:2412100453 dt. 30.12.2024)(1 pac=1 no)	$50.0K	1
4 fdc USP tablet undp(eng/sp/por/fr)(rifampicin 150MG+isoniazid 75MG+pyrazinamide 400MG+ethambutol hcl 275MG	$50.0K	1

Programme DES Nations Unies Pour LE imports 30 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sulfamethoxazole	Advanced Antibiotics	$250.0K	5	1.3%	8
2	Trimethoprim	Advanced Antibiotics	$250.0K	5	0.9%	9

Programme DES Nations Unies Pour LE imports 2 pharmaceutical products across 1 categories into Congo totaling $500.0K.

Programme DES Nations Unies Pour LE — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Programme des Nations Unies pour le (PNUD) is a United Nations agency operating in the Democratic Republic of Congo (DRC). Established in 1976, PNUD collaborates with the DRC government to implement development projects across various sectors, including health, education, and infrastructure. While PNUD's primary focus is on development assistance, it also engages in procurement activities to support its programs. In the pharmaceutical sector, PNUD acts as an importer and distributor, sourcing essential medicines to meet the health needs of the Congolese population. This role is critical in ensuring the availability of vital medications, especially in regions facing health crises or logistical challenges.

2Distribution Network

PNUD's distribution network in the DRC is designed to ensure the efficient delivery of pharmaceutical products to various regions, including remote and conflict-affected areas. The agency collaborates with local logistics partners and utilizes existing infrastructure to facilitate the storage and transportation of medicines. Warehouses are strategically located in major cities and key distribution points to optimize reach and responsiveness. Given the DRC's vast geography and challenging terrain, PNUD employs a combination of road, river, and air transport to navigate logistical obstacles and deliver medicines promptly.

3Industry Role

In the DRC's pharmaceutical supply chain, PNUD functions as a significant importer and distributor, particularly for essential medicines. While not a commercial wholesaler, PNUD's procurement activities are vital for ensuring the availability of critical drugs, especially in underserved regions. The agency's role extends beyond mere distribution; it involves coordinating with the Congolese government, international organizations, and local health authorities to address public health needs effectively. PNUD's involvement is especially pronounced during health emergencies, where timely access to pharmaceuticals is crucial.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Programme DES Nations Unies Pour LE

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

PNUD's pharmaceutical imports from India are concentrated on two primary products: Sulfamethoxazole and Trimethoprim, each accounting for $250,000 in imports. This dual-product focus suggests a strategic approach to sourcing, likely driven by specific therapeutic needs within the DRC. The consistent importation of these products indicates a stable and ongoing relationship with Indian suppliers. However, the lack of diversification in the product portfolio may pose risks, such as supply chain disruptions or changes in demand. To mitigate potential vulnerabilities, PNUD might consider expanding its supplier base and product range, ensuring a more resilient and adaptable procurement strategy.

2Supply Chain Resilience

PNUD's reliance on a limited number of Indian suppliers for its pharmaceutical imports presents both strengths and challenges. The established relationships with suppliers like Emcure Pharmaceuticals Limited, Micro Labs Limited, and Lupin Limited suggest a level of trust and reliability. However, this concentration could expose PNUD to risks such as supply chain disruptions, geopolitical issues, or changes in supplier capabilities. To enhance resilience, PNUD could diversify its supplier base, engage in strategic partnerships, and develop contingency plans to address potential disruptions. Additionally, ensuring that suppliers adhere to international quality standards and maintaining open communication channels are essential steps in strengthening the supply chain.

Importing Pharmaceuticals into Congo — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Congo

1Regulatory Authority & Framework

In the DRC, the Congolese Pharmaceutical Regulatory Authority (ACOREP) is responsible for regulating pharmaceutical products, including their importation, distribution, and use. ACOREP operates under the Ministry of Public Health, Hygiene, and Prevention, ensuring that all pharmaceutical activities comply with national health standards. The regulatory framework governing pharmaceutical imports includes requirements for import licenses, quality control, and adherence to Good Manufacturing Practice (GMP) standards. Importers must obtain prior authorization for pharmaceutical products, which involves submitting detailed documentation and undergoing inspections to verify compliance with established regulations. This framework aims to safeguard public health by ensuring that all pharmaceutical products entering the DRC meet safety and efficacy standards.

2Import Licensing & GMP

Importing pharmaceutical products into the DRC necessitates obtaining an import license from an authorized commercial bank. For shipments valued at $2,500 or more, a Pre-Shipment Inspection (PSI) is mandatory, conducted by Bureau Veritas on behalf of the Congolese Control Office (OCC). This inspection verifies the quality, quantity, and value of the goods before they arrive in the DRC. While GMP certification is officially required, enforcement can be inconsistent; a Certificate of Pharmaceutical Product (CPP) is a critical document for importers. Quality control measures include initial screening using methods like the GPHF Minilab, with more comprehensive analysis performed at WHO-prequalified laboratories abroad. The entire process, from clinical trial application to market entry, is managed by ACOREP, which aims to provide a decision on clinical trial applications within 30 days of submission, following ethics committee approval. Non-compliance with these regulations can lead to significant sanctions, including product recalls and fines.

Programme DES Nations Unies Pour LE — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

PNUD's focus on importing Sulfamethoxazole and Trimethoprim aligns with the therapeutic needs of the DRC, particularly in addressing infectious diseases. The high import values of these products indicate a significant demand within the country. The decision to import these specific antibiotics suggests a strategic approach to meet public health priorities, such as combating bacterial infections and supporting treatment regimens for diseases like HIV/AIDS and tuberculosis. Market demand, driven by disease prevalence and treatment protocols, influences PNUD's procurement decisions, ensuring that the imported products are relevant and necessary for the Congolese population.

2Sourcing Profile

PNUD's sourcing strategy for pharmaceutical products involves importing finished formulations from India, focusing on generic drugs. This approach allows for cost-effective procurement while ensuring the availability of essential medicines. The preference for finished formulations over raw Active Pharmaceutical Ingredients (APIs) or bulk drugs simplifies the supply chain and ensures that the products are ready for distribution upon arrival. India's established pharmaceutical industry, known for its adherence to international quality standards, makes it a reliable source for PNUD's procurement needs.

3Market Positioning

Seller's Guide — How to Become a Supplier to Programme DES Nations Unies Pour LE

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with PNUD, especially if they can offer products that align with the therapeutic needs of the DRC. Expanding the range of imported products beyond Sulfamethoxazole and Trimethoprim could address unmet medical needs and enhance PNUD's ability to respond to diverse health challenges. For Indian exporters, understanding PNUD's procurement processes and regulatory requirements is essential to establish successful partnerships. By offering high-quality, GMP-compliant products and demonstrating a commitment to meeting the DRC's health priorities, Indian suppliers can position themselves as valuable partners in PNUD's mission.

2Requirements & Qualifications

Indian exporters aiming to supply pharmaceutical products to

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Programme DES Nations Unies Pour LE

What products does Programme DES Nations Unies Pour LE import from India?

Programme DES Nations Unies Pour LE imports 2 pharmaceutical products across 1 categories. Top imports: Sulfamethoxazole ($250.0K), Trimethoprim ($250.0K).

Who supplies pharmaceuticals to Programme DES Nations Unies Pour LE from India?

Programme DES Nations Unies Pour LE sources from 7 verified Indian suppliers. The primary supplier is Emcure Pharmaceuticals Limited (57.3% of imports, $746.5K).

What is Programme DES Nations Unies Pour LE's total pharmaceutical import value?

Programme DES Nations Unies Pour LE's total pharmaceutical import value from India is $500.0K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Programme DES Nations Unies Pour LE focus on?

Programme DES Nations Unies Pour LE imports across 1 categories. The largest: Advanced Antibiotics (100.0%).

Get Full Programme DES Nations Unies Pour LE Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.